Eric Pauwels, CEO: PTC Therapeutics PTCT Sell · Filed 24/04/19

Trade details

Type: Insider sale
Amount: $19,785.18
Shares · price: 787 sh · $25.14 a share
Held after: 67,694 sh
Stock: PTC Therapeutics PTCT
Person: Eric PauwelsCEO
Trade date: 24/04/17
Filed: 24/04/19
Days to filing: 2 days

Sold 1.1% of holdings

Share of holding sold: 1.1%

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/18~24/05/17

Eric Pauwels's recent trades

Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$1.3M
17,566 sh
$1.3M
Filed 06/12
Traded 06/10
Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$278.3K
3,711 sh
$278.3K
Filed 06/12
Traded 06/10
Eric PauwelsChief Business Officer
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 plan
PTC Therapeutics
PTCT
$1.6M
21,277 sh
$1.6M
Filed 06/10
Traded 06/10
Eric PauwelsChief Business Officer
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$209.4K
3,019 sh
$209.4K
Filed 02/20
Traded 02/18
Eric PauwelsChief Business Officer
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$209.4K
3,019 sh
$209.4K
Filed 02/18
Traded 02/18